Smartwatch Paroxysmal Arrhythmia Detection Compared with Holter
Launched by CHINESE UNIVERSITY OF HONG KONG · May 17, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a smartwatch can detect heart rhythm problems (called arrhythmias) better than a traditional Holter monitor, which is a device worn for 24 hours to record the heart's activity. Sometimes, arrhythmias do not occur every day, making it hard for the Holter monitor to catch them. The trial aims to see if using a smartwatch that records heart rhythms over four weeks can provide more accurate results for people who experience symptoms like palpitations, dizziness, or pre-syncope (feeling faint).
To participate in this study, you need to be between 18 and 80 years old and have been referred for a Holter exam due to specific symptoms. However, if you already have a diagnosis for your symptoms, have a primary symptom of fainting, or cannot follow the recording instructions, you won't be eligible. If you join the trial, you'll wear a smartwatch that tracks your heart activity, and researchers will compare the results with those from the Holter monitor. This study is important because it could lead to better ways to detect heart rhythm issues, ultimately helping more patients receive timely and accurate diagnoses.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. All patients referred for out-patient Holter exam from age 18 - 80 years old
- • 2. The following indications for Holter exam will be allowed for recruitment
- • Palpitation
- • Pre-syncope
- • Dizziness
- Exclusion Criteria:
- • 1. Patients with a prior ECG diagnosis to explain the symptom
- • 2. Primary symptom is syncope
- • 3. Patient who has no clear indication for Holter exam
- • 4. Pregnant ladies
- • 5. Patients who failed to make a successful recording despite teaching attempts.
- • 6. Patients who cannot read English or Chinese version of consent.
- • 7. Anticipation of non-compliance with recording protocol.
- • 8. Patients who do not have a compatible smart phone (Android 9.0 or newer, or iOS15 or newer)
- • 9. Patients under custody
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0